Source: Hong Leong Assurance,6 September 2021
As a way of advocating its unwavering commitment in offering policyholders only the best in life insurance protection, Hong Leong Assurance (HLA) has lifted the RM1 million cap of its COVID-19 Complimentary Special Benefit Programme 2.0, so that customers with individual medical plans can claim for hospitalisation reimbursement anytime they are admitted to private hospital for severe COVID-19 treatment within the campaign period.
With the pandemic still hovering over us, the welfare of customers has never been more important to HLA. Hence, we have opened up more avenues for customers to receive the best medical care at HLA’s panel of private hospitals for COVID-19 treatments in Categories* 3, 4 and 5. With this campaign, policyholders can claim eligible Hospitalisation Reimbursement for private hospital admissions up to their medical plan limit, as long as their hospital admission date is within the campaign period. This is our way of assisting our customers to manage their medical cost and enabling them to receive the best care they truly deserve, particularly during this trying time.
This benefit is given to our valued customers at no extra cost as part of our COVID-19 Complimentary Special Benefit Programme 2.0 from now until the withdrawal of the programme. Policyholders are advised to look out for the 15-day notice that will be announced on our corporate portal prior to the withdrawal. They may also contact their servicing agents or our customer service hotline for more information on campaign withdrawal.
In addition, this programme alsooffers policyholders coverage for Post-Vaccination Complication with Daily Hospitalisation Benefit ofRM 200 per day up to 7 days, for any complications that may arise after they are vaccinated.
As Malaysia’s leading local life insurer, HLA is constantly strategizing efforts to ensure that the health and wellbeing of our customers are adequately protected during this period of uncertainty. Rest assured, we will continue to expand and strengthen our coverage to make a real impact in their quest to fight the pandemic in this current economic situation.
* Categories of COVID-19 Treatment as defined by MKN:
Category 3: Symptomatic, Pneumonia
Category 4: Symptomatic, Pneumonia, Requiring Supplemental Oxygen
Category 5: Critically-ill with Multi-Organ Involvement
For more information, kindly call our friendly servicing agents, contact our Customer Service at 03-7650 1288, or visit any HLA branches nationwide. Alternatively, you can also log on to www.hla.com.my.